In addition, we describe the natural history of CCM disease in mutation carriers and illustrate the advantages of a combined NGS-based SNV/CNV detection workflow in CCM1/CCM2/CCM3 gene panel analyses. Here, CCM2 is linked to cerebral cavernous malformation.